Abstract
β2-Glycoprotein I is the major autoantigen in the antiphospholipid syndrome (APS), a prothrombotic disorder characterized by the occurrence of either venous or arterial thrombosis. In women it is also associated with an increased risk of obstetric complications such as recurrent miscarriages. We have identified that the plasma protein β2-glycoprotein I in healthy individuals exists in an optimal ratio between two distinct forms, an oxidized and free thiol, reduced form. This ratio is disrupted in pathophysiological conditions associated with increased oxidative stress such as the APS, but also in the setting of age-related macular degeneration and gram-negative sepsis. We have developed assays that quantify plasma/serum levels of total and free thiol β2-glycoprotein I which can potentially be used for risk stratification and prognostic purposes in the early stages of the aforementioned conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Miyakis S et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x
Giannakopoulos B, Passam F, Ioannou Y, Krilis SA (2009) How we diagnose the antiphospholipid syndrome. Blood 113:985–994. https://doi.org/10.1182/blood-2007-12-129627
Krilis SA, Giannakopoulos B (2014) Laboratory methods to detect antiphospholipid antibodies. Hematology 2014:321–328. https://doi.org/10.1182/asheducation-2014.1.321
Agar C, de Groot PG, Marquart JA, Meijers JC (2011) Evolutionary conservation of the lipopolysaccharide binding site of beta(2)-glycoprotein I. Thromb Haemost 106:1069–1075. https://doi.org/10.1160/th11-05-0333
Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368:1033–1044. https://doi.org/10.1056/NEJMra1112830
Passam FH et al (2010) Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Blood 116:1995–1997. https://doi.org/10.1182/blood-2010-02-271494
Ioannou Y et al (2010) Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Blood 116:1961–1970. https://doi.org/10.1182/blood-2009-04-215335
Passam FH et al (2010) Redox control of beta2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. J Thromb Haemost 8:1754–1762. https://doi.org/10.1111/j.1538-7836.2010.03944.x
Ioannou Y et al (2011) Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I. Arthritis Rheum 63:2774–2782. https://doi.org/10.1002/art.30383
Qi M et al (2016) Do beta 2-glycoprotein I disulfide bonds protect the human retina in the setting of age-related macular degeneration? Antioxid Redox Signal 24:32–38. https://doi.org/10.1089/ars.2014.6052
El-Assaad F et al (2017) Beta 2-glycoprotein I protects mice against gram-negative septicaemia in a sexually dimorphic manner. Sci Rep 7:8201. https://doi.org/10.1038/s41598-017-07945-8
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Qi, M., Weaver, J.C., Krilis, S.A., Giannakopoulos, B. (2019). Quantitation of Total and Free Thiol β2-Glycoprotein I Levels for Diagnostic and Prognostic Purposes in the Antiphospholipid Syndrome. In: Hogg, P. (eds) Functional Disulphide Bonds. Methods in Molecular Biology, vol 1967. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9187-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9187-7_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9186-0
Online ISBN: 978-1-4939-9187-7
eBook Packages: Springer Protocols